Consolidated Statements of Cash Flows - USD ($) $ in Millions		9 Months Ended
		Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income (loss)		$ 1,237	$ 1,639
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances		1,070	927
Policy charges and fee income		(900)	(1,702)
Net derivative (gains) losses		121	(2,168)
Credit and intent to sell losses on available for sale debt securities and loans		143	272
Investment (gains) losses, net		501	640
Realized and unrealized (gains) losses on trading securities		(5)	53
Non-cash long-term incentive compensation expense		29	44
Amortization and depreciation		184	122
Equity (income) loss from limited partnerships		(49)	(184)
Remeasurement of liability for future policy benefits		25	38
Change in market risk benefits		(279)	17
Changes in:
Reinsurance recoverable		(258)	(354)
Capitalization of deferred policy acquisition costs		(374)	(552)
Funds withheld payable		87	0
Future policy benefits		161	(459)
Current and deferred income taxes	[1]	(835)	383
Other, net		109	(97)
Net cash provided by (used in) operating activities		967	(1,381)
Proceeds from the sale/maturity/prepayment of:
Fixed maturities, available-for-sale		7,225	14,017
Mortgage loans on real estate		353	901
Trading account securities		146	177
Short-term investments		1,249	(14)
Other		401	270
Payment for the purchase/origination of:
Fixed maturities, available-for-sale		(3,567)	(16,313)
Mortgage loans on real estate		(1,515)	(2,604)
Trading account securities		(163)	(166)
Short-term investments		(1,412)	0
Other		(517)	(603)
Cash settlements related to derivative instruments, net		(1,151)	921
Investment in capitalized software, leasehold improvements and EDP equipment		(34)	(24)
Other, net		(78)	123
Net cash provided by (used in) investing activities		937	(3,315)
Policyholders’ account balances:
Deposits		6,938	11,299
Withdrawals		(7,996)	(4,930)
Transfers (to) from Separate Accounts		822	1,109
Payments of market risk benefits		(198)	(434)
Changes in securities lending payable		113	0
Change in collateralized pledged assets		(100)	38
Change in collateralized pledged liabilities		817	(2,467)
Shareholder dividend paid		(1,653)	(930)
Purchase (redemption) of noncontrolling interests of consolidated company-sponsored investment funds		4	(1)
Other, net		0	29
Net cash provided by (used in) financing activities		(1,253)	3,713
Change in cash and cash equivalents		651	(983)
Cash and cash equivalents, beginning of period		797	1,816
Cash and cash equivalents, end of period		1,448	833
Non-cash transactions from investing and financing activities:
Right-of-use assets obtained in exchange for lease obligations		19	4
Dividend to Parent		$ 0	$ (22)

[1] The nine months ended September 30, 2023 includes a release of $920 million deferred tax valuation allowance. See Note 11 of these Consolidated Financial Statements.